Filtered By:
Source: Current Cancer Drug Targets
Cancer: Thyroid Cancer
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 11 results found since Jan 2013.
AHNAK2 promotes the progression of differentiated thyroid cancer through PI3K/AKT signaling pathway
CONCLUSION: Furthermore, the protein levels of phospho-PI3 Kinase p85 and phospho-AKT were down-regulated in the transfected TC cell. Our study results indicate that AHNAK2 may promote metastasis and proliferation of thyroid cancer through PI3K/AKT signaling pathway. Thus, AHNAK2 may be used as a candidate marker for TC diagnosis and treatment.PMID:36089788 | DOI:10.2174/1568009622666220908092506
Source: Current Cancer Drug Targets - September 12, 2022 Category: Cancer & Oncology Authors: Min Xu Jialiang Wen Qiding Xu Huihui Li Bangyi Lin Adheesh Bhandari Jinmiao Qu Source Type: research
